Dendreon Corp


Dendreon Corp Stock Quote

A biotechnology company focused on the discovery, development and commercialization of novel therapeutics that harness the immune system to fight cancer.

News & Analysis: Dendreon Corp

The Fool has written over 500 articles on Dendreon Corp.


Why Wall Street Hates Dendreon Corp.

Stocks with heavy short interest might signal that something is terribly wrong with a company. Dendreon Corp. sports one of the highest short interests among health-care stocks. Why are short-sellers so bearish on this small-cap biotech?

Why Dendreon Corporation Shares Soared

Dendreon shares spike higher after presenting positive data on Provenge at the American Urological Association's annual meeting. Find out what investors should really be paying attention to instead.

Why Dendreon Corporation Shares Were Hammered

Denderon shareholders run for cover following the company's first-quarter earnings report. Is this dip a buying opportunity, or an omen to keep your distance?

Interactive Chart